Physician-community pharmacist collaborative care in diabetes management: a pilot study

References

• American Diabetes Association. Standards of Medical Care in Diabetes—2008. Diabetes Care. 2008;31:S12-S54.
   PubMed Web of Science ®Google Scholar
• Koopmanschap M. Coping with type II diabetes: the patient's perspective. Diabetologia. 2002;45:S18-S22.
   PubMed Web of Science ®Google Scholar
• Pasquale LR, Kang JH, Manson JE, et al. Prospective study of type 2 diabetes mellitus and risk of primary open-angle glaucoma in women. Ophthalmology. 2006;113:1081-1086.
   PubMed Web of Science ®Google Scholar
• MacIsaac RJ, Panagiotopoulos S, McNeil KJ, et al. Is nonalbuminuric renal insufficiency in type 2 diabetes related to an increase in intrarenal vascular disease? Diabetes Care. 2006;29:1560-1566.
   PubMed Web of Science ®Google Scholar
• Cho YN, Lee KO, Jeong J, et al. The role of insulin resistance in diabetic neuropathy in Koreans with type 2 diabetes mellitus: a 6-year follow-up study. Yonsei Med J. 2014;55:700-708.
   PubMed Web of Science ®Google Scholar
• Franco OH, Steyerberg EW, Hu FB, et al. Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease. Arch Intern Med. 2007;167:1145-1151.
   PubMedGoogle Scholar
• Bamberg F, Parhofer KG, Lochner E, et al. Diabetes mellitus: long-term prognostic value of whole-body MR imaging for the occurrence of cardiac and cerebrovascular events. Radiology. 2013;269:730-737.
   PubMed Web of Science ®Google Scholar
• Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:4-14.
   PubMed Web of Science ®Google Scholar
• Harb H. Compiled literature report on selected health conditions in Lebanon. Lebanese Ministry of Public Health, Directorate of Prevention, Department of Statistics. 2004;115.
   Google Scholar
• IDF Mena members. International Diabetes Federation.2017.Lebanon-39. Available at: https://www.idf.org/our-network/regions-members/middle-east-and-north-africa/members/39-lebanon.html
   Google Scholar
• Costanian C, Bennett K, Hwalla N, et al. Prevalence, correlates and management of type 2 diabetes mellitus in Lebanon: findings from a national population-based study. Diabetes Res Clin Pract. 2014;105:408-415.
   PubMed Web of Science ®Google Scholar
• Funnell MM, Brown TL, Childs BP, et al. National standards for diabetes self-management education. Diabetes Care. 2011;34:S89-S96.
   PubMed Web of Science ®Google Scholar
• Armor BL, Britton ML, Dennis VC, et al. A review of pharmacist contributions to diabetes care in the United States. J Pharm Pract. 2010;23:250-264.
   PubMedGoogle Scholar
• Clifford RM, Davis WA, Batty KT, et al. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care. 2005;28:771-776.
   PubMed Web of Science ®Google Scholar
• Krass I, Armour CL, Mitchell B, et al. The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia. Diabetic Med. 2007;24:677-683.
   PubMed Web of Science ®Google Scholar
• Choe HM, Mitrovich S, Dubay D, et al. Proactive case management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. Am J Manag Care. 2005;11:253-260.
   PubMed Web of Science ®Google Scholar
• Fornos JA, Andrés NF, Andrés JC, et al. A pharmacotherapy follow-up program in patients with type-2 diabetes in community pharmacies in Spain. Pharm World Sci. 2006;28:65-72.
   PubMed Web of Science ®Google Scholar
• Odegard PS, Goo A, Hummel J, et al. Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention. Ann Pharmacother. 2005;39:433-440.
   PubMed Web of Science ®Google Scholar
• Scott DM, Boyd ST, Stephan M, et al. Outcomes of pharmacist-managed diabetes care services in a community health center. Am J Health Syst Pharm. 2006;63:2116-2122.
   PubMed Web of Science ®Google Scholar
• Al Mazroui NR, Kamal MM, Ghabash NM, et al. Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus. Br J Clin Pharmacol. 2009;67:547-557.
   PubMed Web of Science ®Google Scholar
• Jameson JP, Baty PJ. Pharmacist collaborative management of poorly controlled diabetes mellitus: a randomized controlled trial. Am J Manag Care. 2010;16:250-255.
   PubMed Web of Science ®Google Scholar
• Santschi V, Chiolero A, Paradis G, et al. Pharmacist interventions to improve cardiovascular disease risk factors in diabetes. Diabetes Care. 2012;35:2706-2717.
   PubMed Web of Science ®Google Scholar
• Wagner EH, Austin BT, Davis C, et al. Improving chronic illness care: translating evidence into action. Health Aff (Millwood). 2001;20:64-78.
   PubMed Web of Science ®Google Scholar
• Renders CM, Valk GD, Griffin SJ, et al. Interventions to improve the management of diabetes in primary care, outpatient, and community settings: a systematic review. Diabetes Care. 2001;24:1821-1833.
   PubMed Web of Science ®Google Scholar
• McCord AD. Clinical impact of a pharmacist-managed diabetes mellitus drug therapy management service. Pharmacotherapy. 2006;26:248-253.
   PubMed Web of Science ®Google Scholar
• Palaian S, Chhetri AK, Prabhu M. et al. Role of pharmacist in counseling diabetes patients. Internet J Pharmacol. 2004;4:3272.
   Google Scholar
• Arun KP, Murugan R, Kanna MR, et al. The impact of pharmaceutical care on the clinical outcome of diabetes mellitus among a rural patient population. Int J Diabetes Dev Ctries. 2008;28:15-18.
   PubMed Web of Science ®Google Scholar
• Smith M. Pharmacists’ role in improving diabetes medication management. J Diabetes Sci Technol. 2009;3:175-179.
   PubMedGoogle Scholar
• Malathy R, Narmadha M, Ramesh S, et al. Effect of a diabetes counseling programme on knowledge, attitude and practice among diabetic patients in Erode district of South India. J Young Pharm JYP. 2011;3:65-72.
   PubMedGoogle Scholar
• Jarab AS, Alqudah SG, Mukattash TL, et al. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan. JMCP. 2012;18:516-526.
   PubMed Web of Science ®Google Scholar
• Obreli-Neto PR, Guidoni CM, de Oliveira, Baldoni A, et al. Effect of a 36-month pharmaceutical care program on pharmacotherapy adherence in elderly diabetic and hypertensive patients. Int J Clin Pharm. 2011;33:642-649.
   PubMed Web of Science ®Google Scholar
• Grant RW, Devita NG, Singer DE, et al. Improving adherence and reducing medication discrepancies in patients with diabetes. Ann Pharmacother. 2003;37:962-969.
   PubMed Web of Science ®Google Scholar
• Omran D, Guirguis LM, Simpson SH. Systematic review of pharmacist interventions to improve adherence to oral antidiabetic medications in people with type 2 diabetes. Can J Diabetes. 2012;36:292-299.
   Web of Science ®Google Scholar